Acupuncture for Primary Dysmenorrhea: Examining the role of frequency of treatment and mode of stimulation on clinical outcomes

Not Applicable

Completed

• Conditions: Primary Dysmenorrhea; Reproductive Health and Childbirth - Menstruation and menopause; Alternative and Complementary Medicine - Other alternative and complementary medicine

• Registration Number: ACTRN12613000351718
• Lead Sponsor: niversity of Western Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-04-03
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 74

Inclusion Criteria

Women with suspected or confirmed primary dysmenorrhea as defined by the following: * Age 18-45 years * History of period pain beginning before the age of 18 OR after the age of 18 with negative screening for secondary dysmenorrhea* Pain greater than or equal to 3 out of 10 on a numeric rating scale during the first three days of menses for at least two of the past 3 menstrual cycles. * Regular menstrual cycles (28 +/- 7 days) for the last three months. * Understands spoken and written English * Able to give informed consent

Exclusion Criteria

* Previous diagnosis of endometriosis or secondary dysmenorrhea.
*Abdominal Surgery in the previous 3 months
*Injectable or implant contraceptives (Depo provera, Jadelle, Murina ) within the last 3 months
*Oral Contraceptive usage started less than 3 months ago
*Chronic pain conditions ( >14 days per month with pain)
*Current mental health illness
*Neuropathic pain secondary to surgery
*Sterilisation

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umerical rating scale (NRS) for pain. Each subject will keep a menstrual diary provided by the researcher. This will note the day of menses, average and maximum pain per day on an 11 point NRS with 0 being no pain and 10 being the worst pain imaginable. The primary endpoint is a 20% difference in NRS rated average pain severity between groups. [Baseline, each menstrual period for three menstrual cycles and the menstrual period following trial completion ]